David J Yvars Group
- SEC CIK
- 0001836266
- Latest filing
- Jul 7, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by David J Yvars Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q3 2022